为探究低温解除后苜蓿光合作用恢复过程中的限制位点,以‘新牧4号’和‘甘农5号’2个品种紫花苜蓿为材料,测定其低温胁迫及恢复过程中苜蓿叶片光合活性的变化。结果表明,低温胁迫下2个苜蓿品种叶片叶绿素含量、净光合速率以及光系统Ⅱ(p...为探究低温解除后苜蓿光合作用恢复过程中的限制位点,以‘新牧4号’和‘甘农5号’2个品种紫花苜蓿为材料,测定其低温胁迫及恢复过程中苜蓿叶片光合活性的变化。结果表明,低温胁迫下2个苜蓿品种叶片叶绿素含量、净光合速率以及光系统Ⅱ(photosystemⅡ,PSⅡ)活性显著下降,非光化学淬灭系数(nonphotochemical quenching factor,NPQ)显著上升,但对光系统Ⅰ(photosystemⅠ,PSⅠ)的活性无显著影响;其中,‘甘农5号’叶绿素对低温更敏感,含量下降较多。室温恢复72 h后,2个品种苜蓿叶片PSⅡ的活性及净光合速率都有上升但均未恢复至处理前水平;NPQ缓慢下降至处理前水平,‘甘农5号’NPQ较‘新牧4号’更高,表明在恢复过程中仍有过剩光能需通过NPQ消耗。苜蓿叶片的电子传递链在低温下受抑制显著,恢复72 h后PSⅡ受体侧活性基本恢复至处理前,而PSⅡ供体侧活性显著下降。2个品种苜蓿单位反应中心捕获的用于电子传递的能量(energy captured by unit reaction center for electron transfer,ETO/RC)和单位反应中心捕获的用于还原QA的能量(energy captured by the unit reaction center for reducing QA,TRO/RC)在低温处理72 h后显著下降,解除低温后恢复至处理前水平,且2个品种无显著差异;2个苜蓿品种单位反应中心耗散掉的能量(energy dissipated by the unit reaction center,DIO/RC)未恢复至处理前水平,且‘甘农5号’在恢复72 h后DIO/RC显著升高。综上,低温胁迫显著伤害紫花苜蓿叶片光合机构,降低了光合速率,光合速率未恢复到处理前与PSⅡ的活性显著相关,限制光合作用恢复的位点在其供体侧,非光化学淬灭是恢复24 h过剩光能的主要分配途径。展开更多
Diabetic neuropathic pain is one of the most difficult to treat with high levels of reoccurrence and a substantial increase with aging. It involves expensive hospitalizations, often resulting in an amputated lower lim...Diabetic neuropathic pain is one of the most difficult to treat with high levels of reoccurrence and a substantial increase with aging. It involves expensive hospitalizations, often resulting in an amputated lower limb. We explored a variety of methods treating neuropathic pain such as low-level laser, monochromatic near-infrared treatment, TENS, acupuncture and pulsed electromagnetic fields that demonstrated inconclusive, limited or temporary pain relief with minor or short-term improvements in mobility. Research conducted by ultra-low energy technologies reports pain relief and reduction of inflammation as a result of anti-oxidant electron donation transforming free radicals into stable molecules. We report the results of a randomized double blind one-year-long longitudinal clinical study on 10 diabetic mellitus (DM) subjects with chronic neuropathy, treated with ultra-low energy nanotechnology who experienced substantial long-term neuropathic pain relief. Importantly, pain analgesia and improvement in neuropathic symptomatology were not age-contingent. This contradicts past research postulating that age-accumulated inflammation and endothelial dysfunction can further exacerbate diabetic neuropathy. Importantly, a method offering age-independent, cost-effective, long-term neuropathic pain relief and increased mobility has major implications in reducing hospitalization time and overall expenses by offering a solution that enhances quality of life.展开更多
文摘为探究低温解除后苜蓿光合作用恢复过程中的限制位点,以‘新牧4号’和‘甘农5号’2个品种紫花苜蓿为材料,测定其低温胁迫及恢复过程中苜蓿叶片光合活性的变化。结果表明,低温胁迫下2个苜蓿品种叶片叶绿素含量、净光合速率以及光系统Ⅱ(photosystemⅡ,PSⅡ)活性显著下降,非光化学淬灭系数(nonphotochemical quenching factor,NPQ)显著上升,但对光系统Ⅰ(photosystemⅠ,PSⅠ)的活性无显著影响;其中,‘甘农5号’叶绿素对低温更敏感,含量下降较多。室温恢复72 h后,2个品种苜蓿叶片PSⅡ的活性及净光合速率都有上升但均未恢复至处理前水平;NPQ缓慢下降至处理前水平,‘甘农5号’NPQ较‘新牧4号’更高,表明在恢复过程中仍有过剩光能需通过NPQ消耗。苜蓿叶片的电子传递链在低温下受抑制显著,恢复72 h后PSⅡ受体侧活性基本恢复至处理前,而PSⅡ供体侧活性显著下降。2个品种苜蓿单位反应中心捕获的用于电子传递的能量(energy captured by unit reaction center for electron transfer,ETO/RC)和单位反应中心捕获的用于还原QA的能量(energy captured by the unit reaction center for reducing QA,TRO/RC)在低温处理72 h后显著下降,解除低温后恢复至处理前水平,且2个品种无显著差异;2个苜蓿品种单位反应中心耗散掉的能量(energy dissipated by the unit reaction center,DIO/RC)未恢复至处理前水平,且‘甘农5号’在恢复72 h后DIO/RC显著升高。综上,低温胁迫显著伤害紫花苜蓿叶片光合机构,降低了光合速率,光合速率未恢复到处理前与PSⅡ的活性显著相关,限制光合作用恢复的位点在其供体侧,非光化学淬灭是恢复24 h过剩光能的主要分配途径。
文摘Diabetic neuropathic pain is one of the most difficult to treat with high levels of reoccurrence and a substantial increase with aging. It involves expensive hospitalizations, often resulting in an amputated lower limb. We explored a variety of methods treating neuropathic pain such as low-level laser, monochromatic near-infrared treatment, TENS, acupuncture and pulsed electromagnetic fields that demonstrated inconclusive, limited or temporary pain relief with minor or short-term improvements in mobility. Research conducted by ultra-low energy technologies reports pain relief and reduction of inflammation as a result of anti-oxidant electron donation transforming free radicals into stable molecules. We report the results of a randomized double blind one-year-long longitudinal clinical study on 10 diabetic mellitus (DM) subjects with chronic neuropathy, treated with ultra-low energy nanotechnology who experienced substantial long-term neuropathic pain relief. Importantly, pain analgesia and improvement in neuropathic symptomatology were not age-contingent. This contradicts past research postulating that age-accumulated inflammation and endothelial dysfunction can further exacerbate diabetic neuropathy. Importantly, a method offering age-independent, cost-effective, long-term neuropathic pain relief and increased mobility has major implications in reducing hospitalization time and overall expenses by offering a solution that enhances quality of life.
